Azithromycin 1.5g over 5 days compared to 1g single dose in urethral mycoplasma genitalium: Impact on treatment outcome and resistance

Clinical Infectious Diseases

Volumn 64, Issue 3, 2017, Pages 250-256

  Read, Tim R H ^a,b   Fairley, Christopher K ^a,b   Tabrizi, Sepehr N ^c,d,e   Bissessor, Melanie ^a,b   Vodstrcil, Lenka ^b   Chow, Eric P F ^a,b   Grant, Mieken ^b   Danielewski, Jennifer ^c,e   Garland, Suzanne M ^c,d,e   Hocking, Jane S ^f   Chen, Marcus Y ^a,b   Bradshaw, Catriona S ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e ROYAL WOMEN'S HOSPITAL   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Azithromycin; Macrolide resistance; Mycoplasma genitalium; Nongonococcal urethritis

Indexed keywords

AZITHROMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL LOAD; CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; GENE SEQUENCE; GENOTYPE; HETEROSEXUAL MALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MYCOPLASMA GENITALIUM; MYCOPLASMA GENITALIUM URETHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; URETHRITIS; AUSTRALIA; COMPARATIVE STUDY; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MICROBIOLOGY; MUTATION; MYCOPLASMA INFECTIONS; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; AUSTRALIA; AZITHROMYCIN; BACTERIAL LOAD; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MUTATION; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; TREATMENT OUTCOME; URETHRITIS; YOUNG ADULT;

EID: 85019563911     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw719     Document Type: Article

References (21)

1. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev 2011; 24(3):498-514.
2. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One 2008; 3(11):e3618.
3. Bradshaw CS, Jensen JS, Tabrizi SN, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12(7):1149-52.
4. Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47(12): 1546-53.
5. Lau A, Bradshaw CS, Lewis D, et al. The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: A systematic review and meta-analysis. Clin Infect Dis 2015; 61(9):1389-99.
6. Bissessor M, Tabrizi SN, Twin J, et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis 2015; 60(8): 1228-36.
7. Jensen JS, Bradshaw C. Management of Mycoplasma genitalium infections-can we hit a moving target? BMC Infect Dis 2015; 15: 343.
8. Horner PJ, Blee K, Falk L, van der Meijden W, Moi H. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS 2016; 27(11):928-37.
9. Anagrius C, Loré B, Jensen JS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One 2013; 8(4):e61481.
10. Bjornelius E, Anagrius C, Bojs G, et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: A controlled clinical trial. Sex Transm Infect 2008; 84(1): 72-6.
11. Falk L, Enger M, Jensen JS. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women. J Antimicrob Chemother 2015; 70(11):3134-40.
12. Twin J, Taylor N, Garland SM, et al. Comparison of two Mycoplasma genitalium real-time PCR detection methodologies. J Clin Microbiol 2011; 49(3):1140-2.
13. Gundevia Z, Foster R, Jamil MS, McNulty A. Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: follow-up of a clinical cohort. Sexually Transmitted Infections 2015; 91(1): 11-3.
14. Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008; 19(10): 676-9.
15. Chrisment D, Charron A, Cazanave C, Pereyre S, Bébéar C. Detection of macrolide resistance in Mycoplasma genitalium in France. J Antimicrob Chemother 2012; 67(11):2598-601.
16. Unemo M, Endre KM, Moi H. Five-day azithromycin treatment regimen for Mycoplasma genitalium infection also effectively eradicates Chlamydia trachomatis. Acta Derm Venereol 2015; 95(6):730-2.
17. Manhart LE, Jensen JS, Bradshaw CS, Golden MR, Martin DH. Efficacy of antimicrobial therapy for Mycoplasma genitalium infections. Clin Infect Dis 2015; 61 Suppl 8: S802-17.
18. Guschin A, Ryzhikh P, Rumyantseva T, Gomberg M, Unemo M. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin. BMC Infect Dis 2015; 15:40.
19. Chow EP, Tomnay J, Fehler G, et al. Substantial increases in chlamydia and gonorrhea positivity unexplained by changes in individual-level sexual behaviors among men who have sex with men in an Australian sexual health service from 2007 to 2013. Sexually Transmitted Diseases 2015; 42(2): 81-7.
20. Kirkcaldy RD, Zaidi A, Hook EW 3rd, et al. Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010. Ann Intern Med 2013; 158(5 Pt 1): 321-8.
21. Lewis DA. The role of core groups in the emergence and dissemination of antimicrobial-resistant N. gonorrhoeae. Sexually transmitted infections 2013; 89 Suppl 4: iv47-51.